BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38254918)

  • 1. High Expression of THY1 in Intestinal Gastric Cancer as a Key Factor in Tumor Biology: A Poor Prognosis-Independent Marker Related to the Epithelial-Mesenchymal Transition Profile.
    Rohan P; Dos Santos EC; Abdelhay E; Binato R
    Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38254918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and Validation of a Novel Prognostic Signature for Intestinal Type of Gastric Cancer.
    Zhang F; Maswikiti EP; Wei Y; Wu W; Li Y
    Dis Markers; 2021; 2021():5567392. PubMed ID: 34422135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copy number alterations and epithelial‑mesenchymal transition genes in diffuse and intestinal gastric cancers in Mexican patients.
    Larios-Serrato V; Martínez-Ezquerro JD; Valdez-Salazar HA; Torres J; Camorlinga-Ponce M; Piña-Sánchez P; Ruiz-Tachiquín ME
    Mol Med Rep; 2022 May; 25(5):. PubMed ID: 35362543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting expression profiles of gastric precancerous lesions and early gastric cancer to explore crucial molecules in intestinal-type gastric cancer tumorigenesis.
    Zhang Y; Wu X; Zhang C; Wang J; Fei G; Di X; Lu X; Feng L; Cheng S; Yang A
    J Pathol; 2020 Jun; 251(2):135-146. PubMed ID: 32207854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated Network Analysis of microRNAs, mRNAs, and Proteins Reveals the Regulatory Interaction between hsa-mir-200b and CFL2 Associated with Advanced Stage and Poor Prognosis in Patients with Intestinal Gastric Cancer.
    Dos Santos EC; Rohan P; Binato R; Abdelhay E
    Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protein-protein interaction network of intestinal gastric cancer patients reveals hub proteins with potential prognostic value.
    Santos EC; Binato R; Fernandes PV; Ferreira MA; Abdelhay E
    Cancer Biomark; 2022; 33(1):83-96. PubMed ID: 34366321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-551b regulates epithelial-mesenchymal transition and metastasis of gastric cancer by inhibiting ERBB4 expression.
    Song G; Zhang H; Chen C; Gong L; Chen B; Zhao S; Shi J; Xu J; Ye Z
    Oncotarget; 2017 Jul; 8(28):45725-45735. PubMed ID: 28501849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of biomarkers for epithelial-mesenchymal transition-related cells to estimate the prognosis and immune microenvironment in primary gastric cancer by the integrated analysis of single-cell and bulk RNA sequencing data.
    Shen K; Ke S; Chen B; Zhang T; Wang H; Lv J; Gao W
    Math Biosci Eng; 2023 Jun; 20(8):13798-13823. PubMed ID: 37679111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Validation of an Individualized EMT-Related Prognostic Risk Score Formula in Gastric Adenocarcinoma Patients.
    Zhang D; Zhou S; Liu B
    Biomed Res Int; 2020; 2020():7082408. PubMed ID: 32309437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Immunotherapy in Gastric Cancer.
    Song J; Wei R; Huo S; Gao J; Liu X
    Front Immunol; 2022; 13():920512. PubMed ID: 35769483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of altering epithelial-mesenchymal transition in metastatic lymph nodes of gastric cancer.
    Okubo K; Uenosono Y; Arigami T; Yanagita S; Matsushita D; Kijima T; Amatatsu M; Uchikado Y; Kijima Y; Maemura K; Natsugoe S
    Gastric Cancer; 2017 Sep; 20(5):802-810. PubMed ID: 28247164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective Cytotoxicity of the NAMPT Inhibitor FK866 Toward Gastric Cancer Cells With Markers of the Epithelial-Mesenchymal Transition, Due to Loss of NAPRT.
    Lee J; Kim H; Lee JE; Shin SJ; Oh S; Kwon G; Kim H; Choi YY; White MA; Paik S; Cheong JH; Kim HS
    Gastroenterology; 2018 Sep; 155(3):799-814.e13. PubMed ID: 29775598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and Validation of an Epithelial-Mesenchymal Transition-Based Signature in Gastric Cancer by Genomics and Prognosis Analysis.
    Xu H; Wan H; Zhu M; Feng L; Zhang H; Su F
    Biomed Res Int; 2021; 2021():9026918. PubMed ID: 34746312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DDR2 Induces Gastric Cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of Gastric Cancer.
    Wang YG; Xu L; Jia RR; Wu Q; Wang T; Wei J; Ma JL; Shi M; Li ZS
    Dig Dis Sci; 2016 Aug; 61(8):2272-2283. PubMed ID: 27010547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT.
    Hu Q; Masuda T; Kuramitsu S; Tobo T; Sato K; Kidogami S; Nambara S; Ueda M; Tsuruda Y; Kuroda Y; Ito S; Oki E; Mori M; Mimori K
    PLoS One; 2020; 15(10):e0241140. PubMed ID: 33095806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased long noncoding RNA SPRY4-IT1 contributing to gastric cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
    Xie M; Nie FQ; Sun M; Xia R; Liu YW; Zhou P; De W; Liu XH
    J Transl Med; 2015 Aug; 13():250. PubMed ID: 26238992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Clinicopathological Features and Overall Survival of Patients With Gastric Neuroendocrine Carcinoma.
    Xu B; Chu Y; Hu Q; Song Q
    Technol Cancer Res Treat; 2021; 20():15330338211055340. PubMed ID: 34806493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of vinculin predicts poor prognosis and distant metastasis and associates with influencing tumor-associated NK cell infiltration and epithelial-mesenchymal transition in gastric cancer.
    Li H; Wang C; Lan L; Behrens A; Tomaschko M; Ruiz J; Su Q; Zhao G; Yuan C; Xiao X; Li B; Yan L; Wu W; Li W; Chen J; He Y; Zhang C
    Aging (Albany NY); 2021 Feb; 13(4):5197-5225. PubMed ID: 33535187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.
    Ye J; Huang J; Xu J; Huang Q; Wang J; Zhong W; Lin X; Li Y; Lin X
    BMC Cancer; 2017 Sep; 17(1):626. PubMed ID: 28874138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-140-5p inhibits cell proliferation, migration and promotes cell apoptosis in gastric cancer through the negative regulation of THY1-mediated Notch signaling.
    Wu K; Zou J; Lin C; Jie ZG
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31123165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.